Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present Interpace Diagnostics Group, Inc. (NASDAQ: IDXG).

Full DD Report for IDXG

You must become a subscriber to view this report.


Recent News from (NASDAQ: IDXG)

Interpace Diagnostics Group's (IDXG) CEO Jack Stover on Q1 2018 Results - Earnings Call Transcript
Interpace Diagnostics Group, Inc. (IDXG) Q1 2018 Earnings Conference Call May 15, 2018 8:30 am ET Executives Jack Stover - President and Chief Executive Officer Jim Early - Chief Financial Officer Analysts Jason McCarthy - Maxim Group Francois Brisebois - Laidlaw Yi Chen...
Source: SeekingAlpha
Date: May, 15 2018 14:16
Interpace Diagnostics misses by $0.03, beats on revenue
Interpace Diagnostics (NASDAQ: IDXG ): Q1 EPS of -$0.11 misses by $0.03 . More news on: Interpace Diagnostics Group, Inc., Earnings news and commentary, Consumer stocks news, , Read more ...
Source: SeekingAlpha
Date: May, 15 2018 08:06
Interpace Diagnostics Group Reports First Quarter 2018 Financial Results, Business Progress and Recent Accomplishments
Revenue Grew 39% Over the Prior Year’s Quarter and 10% Over the Prior Period Record Quarterly Revenue of $4.8 Million and Record Quarterly Cash Receipts of $4.4 Million Cash & Cash Equivalents Remain Strong at $12.6 Million with No Long-Term Debt     ...
Source: GlobeNewswire
Date: May, 15 2018 08:00
Interpace Diagnostics Announces Launch of New Thyroid Test
BOSTON, May 14, 2018 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (NASDAQ:IDXG) (“Interpace” or “the Company”), a fully integrated commercial and bioinformatics company that provides clinically useful molecular diagnostic tests, bioinformatics, and patho...
Source: GlobeNewswire
Date: May, 14 2018 08:30
Interpace Diagnostics to Host Conference Call and Webcast to Discuss First Quarter 2018 Financial Results, Business Progress and Recent Accomplishments on Tuesday, May 15, 2018
PARSIPPANY, N.J., May 11, 2018 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (NASDAQ:IDXG) (“Interpace” or “the Company”), a fully integrated commercial and bioinformatics company that provides clinically useful molecular diagnostic tests and pathology se...
Source: GlobeNewswire
Date: May, 11 2018 09:10
Interpace Diagnostics Announces Expanded Coverage Among Blue Cross Blue Shield Plans
PARSIPPANY, N.J., May 10, 2018 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (NASDAQ:IDXG) (“Interpace” or “the Company”), a fully integrated commercial and bioinformatics company that provides clinically useful molecular diagnostic tests, bioinformatics,...
Source: GlobeNewswire
Date: May, 10 2018 09:00
Foundation Medicine: To Profit From The Increasing Trend Of Personalized Treatment
Our game is to recognize a big idea when it comes along, when one doesn’t come along very often. Opportunity comes to the prepared mind. - Charlie Munger Foundation Medicine (NASDAQ: FMI ) is a highly interesting bioscience that came to our attention by a subscriber of Integrat...
Source: SeekingAlpha
Date: April, 23 2018 02:23
Interpace Diagnostics: Assessing The Fundamentals Of A Growth Bioscience
You’ll do better if you have a passion for something in which you have an aptitude. If Warren Buffett had gone into ballet, no one would have heard of him. —Charlie Munger Interpace Diagnostics (NASDAQ: IDXG ) is a highly interesting bioscience, focusing on the innovation a...
Source: SeekingAlpha
Date: April, 22 2018 20:50
Interpace Diagnostics Enters Agreement with One of the Largest, Integrated Health Systems in the US
PARSIPPANY, N.J., April 18, 2018 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group (NASDAQ:IDXG) (“Interpace” or “the Company”), a fully integrated commercial and bioinformatics company that provides clinically useful molecular diagnostic tests and pathology servic...
Source: GlobeNewswire
Date: April, 18 2018 08:30
Detailed Research: Economic Perspectives on AmerisourceBergen, Builders FirstSource, Twilio, Gannett Co., Intel, and Interpace Diagnostics Group - What Drives Growth in Today's Competitive Landscape
NEW YORK, April 16, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of AmerisourceBergen Corporation (NYSE:ABC), Builders FirstSource, Inc. (NA...
Source: GlobeNewswire
Date: April, 16 2018 08:25

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-08-171.011.031.031.01251,788
2018-08-161.001.021.040.9854223,016
2018-08-151.041.021.0491.01152,723
2018-08-141.041.0351.051.02380,662
2018-08-131.081.0361.081.02368,735

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-08-1717,056146,01511.6810Cover
2018-08-1646,056103,04544.6950Short
2018-08-1535,56765,02654.6966Short
2018-08-14146,573217,86667.2767Short
2018-08-1324,818137,77718.0132Cover

* Short Mode

Short Analysis provided by Squeeze Report. Get a complete short report on IDXG.


About Interpace Diagnostics Group, Inc. (NASDAQ: IDXG)

Logo for Interpace Diagnostics Group, Inc. (NASDAQ: IDXG)

Not available

 

Contact Information

 

 

Current Management

  • Charles T. Saldarini / CEO
  • Steven K. Budd / President, COO
  • Bernard C. Boyle / CFO

Current Share Structure

  • Market Cap: $22,165,820 - 03/21/2018
  • Issue and Outstanding: 22,163,604 - 08/04/2017

 


Recent Filings from (NASDAQ: IDXG)

Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: May, 15 2018
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: May, 15 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: May, 07 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: May, 07 2018
Official notification to shareholders of matters to be brought to a vote (Proxy)
Filing Type: DEF 14AFiling Source: edgar
Filing Date: April, 30 2018
Securities offered to employees under employee benefit plans
Filing Type: S-8Filing Source: edgar
Filing Date: April, 30 2018
Official notification to shareholders of matters to be brought to a vote (Proxy)
Filing Type: DEF 14AFiling Source: edgar
Filing Date: April, 30 2018
Securities offered to employees under employee benefit plans
Filing Type: S-8Filing Source: edgar
Filing Date: April, 30 2018
Annual report with a comprehensive overview of the company
Filing Type: 10-KFiling Source: edgar
Filing Date: March, 23 2018
Annual report with a comprehensive overview of the company
Filing Type: 10-KFiling Source: edgar
Filing Date: March, 23 2018

 

 


Daily Technical Chart for (NASDAQ: IDXG)

Daily Technical Chart for (NASDAQ: IDXG)


Stay tuned for daily updates and more on (NASDAQ: IDXG)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (NASDAQ: IDXG)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

DD Report
@DDReports

 

 


Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in IDXG is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received up to $100,000 worth of crypto currency from a non-affiliated third party for the publication and circulation of this report. DD Report does not own any shares of IDXG and does not buy, sell, or trade any shares of IDXG. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: http://dd.report/disclaimer/